Establishing China's National Standard for the Recombinant Adenovirus Type 5 Vector–Based Ebola Vaccine (Ad5-EBOV) Virus Titer-Reference-Cited by-同舟云学术

Establishing China's National Standard for the Recombinant Adenovirus Type 5 Vector–Based Ebola Vaccine (Ad5-EBOV) Virus Titer

Published:2018-12 Issue:4 Volume:29 Page:226-232
ISSN:2324-8637
Container-title:Human Gene Therapy Clinical Development
language:en
Short-container-title:Human Gene Therapy Clinical Development

Author:

Li Yuhua¹²,Wang Ling¹,Zhu Tao³,Wu Shipo⁴,Feng Liqiang⁵,Cheng Ping²,Liu Jingjing¹,Wang Junzhi¹

Affiliation:

1. National Institute for Food and Drug Control, Beijing, P.R. China.

2. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China.

3. Tianjin CanSino Biologics, Inc. Tianjin, P.R. China.

4. Beijing Institute of Biotechnology, Beijing, P.R. China.

5. Guangzhou Institutes of Biomedicine and Heath, Chinese Academy of Sciences, Guangzhou, P.R. China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics (clinical)

Link

https://www.liebertpub.com/doi/pdf/10.1089/humc.2018.129

Reference19 articles.

1. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

2. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

3. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

4. Open-label phase I clinical trial of Ad5-EBOV in Africans in China

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine;Frontiers in Immunology;2024-04-30

2. Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses;PLOS ONE;2024-04-16

3. Harnessing Nanovaccines for Effective Immunization─A Special Concern on COVID-19: Facts, Fidelity, and Future Prospective;ACS Biomaterials Science & Engineering;2023-12-14

4. A novel in vitro system of supported planar endosomal membranes (SPEMs) reveals an enhancing role for cathepsin B in the final stage of Ebola virus fusion and entry;Microbiology Spectrum;2023-10-17

5. Predicting the combined effects of case isolation, safe funeral practices, and contact tracing during Ebola virus disease outbreaks;PLOS ONE;2023-01-17